For US Veterinary Professionals Only

1 DOSE. 12 WEEKS.*
IMPROVED COMPLIANCE

DELIVER THE DIFFERENCE OF BRAVECTO®

Bravecto is helping veterinarians nationwide make a difference in dog and cat owners' lives. That's because only Bravecto takes care of killing fleas and ticks for 12 weeks* with one convenient chew or topical dose.

Long-Lasting

Potentially fewer gaps in protection with 12-week dosing period

Fast-Acting

Starts killing fleas and ticks within hours and lasts for 12 weeks*1-3,8-10

Safe

Proven safe and effective for both dogs and cats for 12 weeks*1-7

Enhances Compliance

Convenient long-lasting protection means less chance of noncompliance

HEAR HOW VETERINARIANS ARE ENHANCING PET OWNER COMPLIANCE WITH BRAVECTO

Dr. Dan Markwalder
Illinois

“Though we had very high expectations for Bravecto, we were totally blown away with the numbers. The metrics that we saw were double digits – somewhere between 40% and 50% increases when we brought Bravecto onboard.”

 
 
   
   

I irrevocably grant to Intervet Inc., a subsidiary of Merck & Co., Inc. and its affiliates and their respective officers, directors, employees, agents, successors, licensees and assigns (collectively, "MERCK ANIMAL HEALTH"), the right to take, record, publish or obtain testimonials or other statements from me (collectively, the "Statements") and use, copy, modify, adapt, distribute, publish, display, exhibit and otherwise publish or display in any media, by any means, methods and technologies now known or hereafter to become known, either in whole or in part, the Statements for commercial and business purposes, including, but not limited to, educational, advertising, marketing and promotional materials.

I agree that no advertisement or other material need be submitted to me for any approval. I further waive any and all rights that I may have over the use, distribution, transfer, display, exhibition or other publication of any Statements, including, without limitation, any right to inspect and/or approve such use, publication, distribution, transfer, display, exhibition or other exploitation so long as such Statements are not substantively altered.

I hereby release and discharge, and agree to release and discharge, MERCK ANIMAL HEALTH and its affiliates and their respective officers, directors, employees, agents, successors, licensees and assigns from, and shall neither sue nor bring any proceeding against any such parties for, any claim or cause of action, whether now known or unknown, for defamation, violation of any moral rights, invasion of right of privacy, publicity or personality or any similar matter, or based upon or relating to any use, copying, modification, adaptation, publication, distribution, transfer, display, exhibition or other exploitation of any or all of the Statements.

I further agree that MERCK ANIMAL HEALTH has the right to attribute the Statements (or statements in different words which have substantially the same meaning) to me, which is an expression of my personal experience and belief, including, without limitation, the use of my name and image in connection therewith. I further acknowledge that I am to receive no compensation from MERCK ANIMAL HEALTH relating to the use, copying, modification, adaptation, publication, distribution, transfer, display, exhibition or other exploitation of any or all of the Statements as set forth in this Release or the use of my name and/or image in connection therewith.

Nothing herein will constitute any obligation on MERCK ANIMAL HEALTH to make any use of the Statements or use of any of the rights set forth herein.

I represent and warrant that I am over the age of eighteen (18) years and have read and understand the contents of this Release.  

 

BRAVECTO ON TV

We’re supporting Bravecto with high-visibility marketing on television and online. See how we’re driving pet owners to your clinic.

WATCH NOW

RESOURCES

View and download Bravecto resource materials to support you as you inform your team and customers.

READ PUBLISHED BRAVECTO STORIES

Read Stories

GET RESOURCES FOR IN YOUR CLINIC

Get Resources

SHARE YOUR BRAVECTO EXPERIENCE WITH US

Contact Us

To get tips and resources to talk to your clients about the best flea and tick options for their pets:

  1. Visit www.animalhealthprofessionals.com
  2. Register/Login and go to
    Education > Learning Channel > Companion Animals
  3. Watch these three videos
    • Stay Sharp: Flea & Tick Preventatives
    • Stay Sharp: Pet Owner Communications
    • Stay Sharp: Practice Management

It only takes 3 easy steps to register with Merck Animal Health for additional learning opportunities and training on Bravecto and other products.

OFFER PET OWNERS SAVINGS

One dose of Bravecto lasts 12 weeks* compared to other products which must be given every month. That already makes it a cost-effective option for pet owners. But now, you can help pet owners save even more with Bravecto.

DISCOVER SPECIAL OFFERS

CONTACT US ABOUT THE 12-WEEK* DIFFERENCE

Have questions or comments about Bravecto? Contact us today so that we can help you start prescribing Bravecto for the dogs and cats at your clinic.

Contact Us

For technical assistance or to report a suspected adverse drug reaction, contact Merck Animal Health at 1-800-224-5318.

Bravecto kills fleas and prevents flea infestations. Bravecto Chew and Bravecto Topical Solution for Dogs kills ticks (black-legged tick, American dog tick, and brown dog tick) for 12 weeks and also kills lone star ticks for 8 weeks. Bravecto Topical for Cats kills ticks (black-legged tick) for 12 weeks and American dog ticks for 8 weeks.

IMPORTANT SAFETY INFORMATION:
Bravecto has not been shown to be effective for 12-weeks’ duration in puppies or kittens less than 6 months of age. Bravecto Chew: The most common adverse reactions recorded in clinical trials were vomiting, decreased appetite, diarrhea, lethargy, polydipsia, and flatulence. Bravecto is not effective against lone star ticks beyond 8 weeks of dosing. Bravecto Topical Solution for Dogs: The most common adverse reactions recorded in clinical trials were vomiting, hair loss, diarrhea, lethargy, decreased appetite, and moist dermatitis/rash. Bravecto is not effective against lone star ticks beyond 8 weeks of dosing. For topical use only. Avoid oral ingestion. Use caution in dogs with a history of seizures. Seizures have been reported in dogs receiving fluralaner, even in dogs without a history of seizures. Bravecto Topical for Cats: The most common adverse reactions recorded in clinical trials were vomiting, itching, diarrhea, hair loss, decreased appetite, lethargy, and scabs/ulcerated lesions. Bravecto is not effective against American dog ticks beyond 8 weeks of dosing. For topical use only. Avoid oral ingestion. The safety of Bravecto has not been established in breeding, pregnant and lactating cats. Use with caution in cats with a history of neurologic abnormalities. Neurologic abnormalities have been reported in cats receiving Bravecto, even in cats without a history of neurologic abnormalities.

References: 1. Bravecto Chew for Dogs [prescribing information]. Madison, NJ: Merck Animal Health; 2014. 2. Bravecto Topical Solution for Dogs [prescribing information]. Madison, NJ: Merck Animal Health; 2016. 3. Bravecto Topical Solution for Cats [prescribing information]. Madison, NJ: Merck Animal Health; 2016. 4. Freedom of Information Summary, NADA 141-426. Approved May 15, 2014. 5. Freedom of Information Summary, NADA 141-459. Approved 2016. 6. Walther FM, Allan MJ, Roepke RKA, Nuernberger MC. Safety of fluralaner chewable tablets (Bravecto™), a novel systemic antiparasitic drug, in dogs after oral administration. Parasites & Vectors (2014) 7:87. 7. Walther FM, Allan MJ, Roepke RKA, Nuernberger MC. Safety of fluralaner, a novel systemic antiparasitic drug, in MDR1(-/-) collies after oral administration. Parasites & Vectors (2014) 7:86. 8. Burgio et al. Parasites & Vectors (2016) 9:626. 9. Taenzler et al. Parasites & Vectors (2014) 7:567. 10. Wengenmayer et al. Parasites & Vectors (2014) 7:525.

Contact Us